Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Schisandra chinensis berry
Fresh or differently processed schisandra berries used in specific TCM preparations for different clinical applications.
Schisandra chinensis (Schisandra Berry Black) is a traditional Chinese medicinal berry used for hepatoprotection, adaptogenic support, and cognitive enhancement. Its primary active compounds include schisandrins A, B, C, gomisins A, B, C, N, wuweizisu C, schisandrol, and citric acid, which collectively modulate liver enzymes, antioxidant pathways, and neurotransmitter systems. Evidence level C indicates limited clinical trials supporting its use for liver conditions, respiratory issues, and fatigue.
Schisandra constituents, particularly schisandrins and gomisins, enhance hepatic glutathione S-transferase and superoxide dismutase activities, reducing oxidative stress and promoting hepatocyte regeneration. They also inhibit CYP3A4 and CYP2C9, increasing bioavailability of co-administered drugs. Adaptogenic effects involve modulation of the HPA axis and increased nitric oxide production, while nootropic actions are linked to upregulation of cholinergic receptors and BDNF in the hippocampus.
Fresh or differently processed schisandra berries used in specific TCM preparations for different clinical applications.
Schisandra chinensis (Schisandra Berry Black) is a traditional Chinese medicinal berry used for hepatoprotection, adaptogenic support, and cognitive enhancement. Its primary active compounds include schisandrins A, B, C, gomisins A, B, C, N, wuweizisu C, schisandrol, and citric acid, which collectively modulate liver enzymes, antioxidant pathways, and neurotransmitter systems. Evidence level C indicates limited clinical trials supporting its use for liver conditions, respiratory issues, and fatigue.
Schisandra constituents, particularly schisandrins and gomisins, enhance hepatic glutathione S-transferase and superoxide dismutase activities, reducing oxidative stress and promoting hepatocyte regeneration. They also inhibit CYP3A4 and CYP2C9, increasing bioavailability of co-administered drugs. Adaptogenic effects involve modulation of the HPA axis and increased nitric oxide production, while nootropic actions are linked to upregulation of cholinergic receptors and BDNF in the hippocampus.